These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Extended experience with t8ioridazine in the treatment of hospitalized adolescents. Rinsley DB Dis Nerv Syst; 1968 Jan; 29(1):36-7. PubMed ID: 5635745 [No Abstract] [Full Text] [Related]
24. Drug therapy reviews. Propoxyphene: a review. Miller RR J Maine Med Assoc; 1977 Mar; 68(3):86-9, 103-9. PubMed ID: 320282 [No Abstract] [Full Text] [Related]
25. Reports of propoxyphene dependence. Wolfe R JAMA; 1969 Dec; 210(13):2398. PubMed ID: 5395399 [No Abstract] [Full Text] [Related]
26. Pulmonary arteriole foreign body granulomata associated with angiomatoids resulting from the intravenous injection of oral medications, e. g., propoxyphene hydrochloride (Darvon). Butz WC J Forensic Sci; 1969 Jul; 14(3):317-26. PubMed ID: 5802944 [No Abstract] [Full Text] [Related]
27. [Psychopharmacological mass screening using Inofal]. Eckmann F; Immich H; Newmann H; SchÀpperle O; Schwarz H Int Pharmacopsychiatry; 1971; 6(1):23-7. PubMed ID: 5163165 [No Abstract] [Full Text] [Related]
28. Physicians asked to write 'No Refill' on propoxyphene Rxes. FDA Drug Bull; 1980 Jul; 10(2):11. PubMed ID: 7399191 [No Abstract] [Full Text] [Related]
29. [Dextro propoxyphene--evaluation of abuse and poisoning risks]. Guinne LM; Petrovics J; AnggÄrd E Lakartidningen; 1976 Apr; 73(18):1731-5. PubMed ID: 1263710 [No Abstract] [Full Text] [Related]
30. Thioridazine in the treatment of anxiety in military dependents. Smith DB Dis Nerv Syst; 1967 Jul; 28(7 Pt 1):455-7. PubMed ID: 4951981 [No Abstract] [Full Text] [Related]
31. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774 [TBL] [Abstract][Full Text] [Related]
33. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Shiffman S Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988 [TBL] [Abstract][Full Text] [Related]
34. Patterns of propoxyphene abuse. Chambers CD; Taylor WJ Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):240-50. PubMed ID: 5550421 [No Abstract] [Full Text] [Related]
35. Anxiety and risk for substance dependence among late adolescents/young adults. Lopez B; Turner RJ; Saavedra LM J Anxiety Disord; 2005; 19(3):275-94. PubMed ID: 15686857 [TBL] [Abstract][Full Text] [Related]
36. [Psychopharmacological treatment of anxiety]. Perez de Francisco C Prensa Med Mex; 1971 Oct; 36(9):385-94. PubMed ID: 5164957 [No Abstract] [Full Text] [Related]
37. [Control of craving for methamphetamine: development of scales for dependence and search for medicines for treatment]. Ogai Y; Haraguchi A; Kondo A; Takamatsu Y; Yamamoto H; Sendoo E; Ikeda K Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Oct; 25(5):227-33. PubMed ID: 16313099 [TBL] [Abstract][Full Text] [Related]
38. [Unusual case of thioridazine and thisercine dependence]. Maksimowska M Psychiatr Pol; 1980; 14(5):547-8. PubMed ID: 6110215 [No Abstract] [Full Text] [Related]
39. Propoxyphene hydrochloride, a drug of abuse. Claghorn JL; Schoolar JC JAMA; 1966 Jun; 196(12):1089-91. PubMed ID: 5952479 [No Abstract] [Full Text] [Related]
40. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Barkin RL; Barkin SJ; Barkin DS Am J Ther; 2006; 13(6):534-42. PubMed ID: 17122535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]